4551 鳥居薬品

4551
2019/01/22
時価
713億円
PER 予
23.16倍
2010年以降
9.98-56.41倍
(2010-2017年)
PBR
0.8倍
2010年以降
0.49-1.45倍
(2010-2017年)
配当 予
1.94%
ROE 予
3.44%
ROA 予
2.86%
資料
Link

イベントチャート

2018/08/22~2019/01/22

イベント情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2019
01/222,4992,5172,4462,476-0.4%24,000713億880万-1.9%
01/212,4842,5192,4832,486+0.61%21,000715億9680万-1.43%
01/182,4672,5072,4672,471+0.2%14,800711億6480万-1.98%
01/172,5062,5172,4602,466-1.52%33,800710億2080万-2.38%
01/162,5332,5332,4942,504-0.71%24,900721億1520万-0.95%
01/152,4882,5962,4862,522-0.28%27,600726億3360万-0.32%
01/112,5302,5342,4722,529-0.82%36,900728億3520万-0.08%
01/102,5502,5662,5292,5500%22,400734億4000万+0.59%
01/092,5212,5722,5142,550+1.15%41,800734億4000万+0.99%
01/082,4912,5452,4742,521+0.4%41,100726億480万+0.2%
01/072,5622,5882,4952,511+0.97%37,400723億1680万+0.12%
01/042,4082,4932,3852,487+2.22%37,700716億2560万-0.48%
2018
12/282,4982,4992,4152,433-2.68%16,000700億7040万-2.37%
12/272,4672,5002,4072,500+3.95%46,100720億+0.56%
12/262,3612,4472,3612,405+1.18%50,600692億6400万-2.99%
12/252,4392,4392,3652,377-4.5%43,600684億5760万-4.08%
12/212,5432,5432,4172,489-2.16%50,300716億8320万+0.36%
12/202,6022,6272,5432,544-3.23%43,700732億6720万+2.75%
12/192,5702,6852,5372,629+1.12%72,800757億1520万+6.44%
12/182,6002,6312,5622,600-1.66%46,900748億8000万+5.65%
12/172,6352,6982,6232,644-0.68%48,200761億4720万+7.83%
12/14(IR情報)16:00 抗HIV薬6品の日本国内における独占的販売権に関する契約の終了日確定のお知らせ
12/142,6852,6852,6422,662-0.75%51,300766億6560万+8.96%
12/132,6002,7192,6002,682+3.55%95,800772億4160万+10.23%
12/13(空売り報告)Integrated Core Strategies (Asia) Pte. Ltd. 169,800株(0.58%)-0.02%
12/122,4992,6202,4832,590+4.9%98,800745億9200万+6.98%
12/112,4452,4992,4002,469+2.07%47,100711億720万+2.32%
12/102,5242,5242,4122,419-2.22%70,400696億6720万+0.5%
12/072,5072,5362,3402,474-4.29%176,900712億5120万+3%
12/062,5362,5892,5232,585+2.3%50,500744億4800万+7.93%
12/052,5242,5672,5172,527-0.47%43,300727億7760万+5.69%
12/042,5162,5842,5102,539-0.59%79,400731億2320万+6.32%
12/032,4802,5912,4802,554-2.89%251,600735億5520万+7.09%
11/302,3502,6662,3502,630+14.15%520,300757億4400万+10.5%
11/29(IR情報)15:00 抗HIV薬6品の日本国内における独占的販売権に関する契約の終了について
11/292,3302,3492,3012,304-1.12%23,200663億5520万-2.91%
11/282,3142,3492,3102,330+0.69%20,100671億400万-2.22%
11/272,2992,3192,2832,314+0.65%26,600666億4320万-3.22%
11/262,2752,3212,2752,299+0.39%27,000662億1120万-4.25%
11/26(空売り報告)Integrated Core Strategies (Asia) Pte. Ltd. 174,079株(0.6%)+0.1%
11/222,2282,3062,2282,290-0.26%83,100659億5200万-5.1%
11/212,3272,3272,2952,296-1.54%43,800661億2480万-5.32%
11/202,3722,3722,3232,332-2.02%23,800671億6160万-4.27%
11/192,3972,3982,3702,380-1.37%34,100685億4400万-2.66%
11/162,3932,4292,3862,413+0.84%20,700694億9440万-1.59%
11/152,3812,4062,3792,393-0.5%19,300689億1840万-2.64%
11/142,4022,4092,3632,405+0.97%44,000692億6400万-2.43%
11/132,3772,4022,3662,382-0.38%38,100686億160万-3.72%
11/122,3902,4082,3732,391-0.71%17,300688億6080万-3.9%
11/092,4192,4712,4072,408-0.86%25,100693億5040万-3.83%
11/082,4102,4562,4102,429+2.23%29,300699億5520万-3.5%
11/072,3782,4082,3622,376-0.25%27,600684億2880万-6.05%
11/062,3772,4202,3712,382+2.19%36,200686億160万-6.22%
11/052,3312,3722,2962,331+1.97%64,300671億3280万-8.7%
11/022,3112,3202,2602,286-0.61%119,700658億3680万-11.05%
11/012,6372,6372,3002,300-7.52%128,400662億4000万-11.09%
11/01(空売り報告)Integrated Core Strategies (Asia) Pte. Ltd. 145,000株(0.5%)新規
10/31(IR情報)15:00 2018年12月期第3四半期決算参考資料
10/31(IR情報)15:00 平成30年12月期第3四半期決算短信〔日本基準〕(非連結)
10/312,4532,5262,4532,487+1.72%38,400716億2560万-4.49%
10/302,4312,4822,4212,445-0.45%45,100704億1600万-6.47%
10/292,4352,5172,4012,456+0.33%47,000707億3280万-6.33%
10/262,4422,4672,4002,448+0.41%61,100705億240万-6.81%
10/252,5052,5142,4302,438-4.58%43,600702億1440万-7.48%
10/242,5322,5622,5262,555+0.95%21,400735億8400万-3.44%
10/232,5602,5742,5312,531-1.44%40,000728億9280万-4.45%
10/222,5672,5822,5422,568-0.96%17,000739億5840万-3.09%
10/192,5612,5942,5582,5930%15,600746億7840万-2.15%
10/182,5792,6192,5782,593+0.27%32,700746億7840万-1.97%
10/172,5442,5902,5212,586+1.73%45,900744億7680万-1.97%
10/162,5332,5552,5212,542-0.47%31,200732億960万-3.38%
10/152,5662,5972,5452,554-0.39%36,300735億5520万-2.63%
10/122,5652,6062,5442,564-0.04%52,000738億4320万-1.95%
10/112,5552,5752,5102,565-2.66%74,600738億7200万-1.5%
10/102,7122,7122,6252,635-3.44%81,700758億8800万+1.54%
10/092,7762,7762,7002,729-2.12%46,000785億9520万+5.61%
10/052,7482,8102,7282,788+1.42%41,700802億9440万+8.48%
10/042,7402,7582,7092,749+0.99%49,900791億7120万+7.68%
10/032,6522,7342,6522,722+2.64%43,700783億9360万+7.29%
10/022,6672,6952,6432,652-2.39%65,100763億7760万+4.57%
10/012,7252,7672,7032,717-0.66%45,700782億4960万+7.05%
09/282,7472,7872,7052,735+0.59%56,600787億6800万+7.76%
09/272,7312,7312,6592,719-0.51%82,600783億720万+7.17%
09/262,7412,7712,7002,733+0.07%40,000787億1040万+7.9%
09/252,6682,7312,6632,731+3.6%104,400786億5280万+7.99%
09/212,5812,6502,5812,636+1.78%77,100759億1680万+4.4%
09/202,6782,6782,5812,590-2.7%80,600745億9200万+2.57%
09/192,7092,7092,6482,662-1.08%100,100766億6560万+5.3%
09/182,6322,6922,5952,691+2.28%79,300775億80万+6.45%
09/142,6022,6732,5952,631+2.14%118,200757億7280万+4.2%
09/132,5792,5902,5532,576+0.7%74,800741億8880万+2.1%
09/122,4712,5592,4542,558+3.56%118,600736億7040万+1.35%
09/112,4232,4902,4222,470+2.28%94,200711億3600万-2.18%
09/102,4092,4202,3912,415+0.25%68,300695億5200万-4.58%
09/072,3472,4092,3412,409+2.51%134,000693億7920万-5.05%
09/062,3422,3642,3312,350+0.47%49,300676億8000万-7.63%
09/052,3002,3502,2922,339+1.34%77,700673億6320万-8.45%
09/042,3342,3362,3052,308-0.99%85,400664億7040万-10.09%
09/032,3752,3752,3302,331-1.56%104,200671億3280万-9.76%
08/312,3582,3852,3522,368+0.3%76,600681億9840万-9.1%
08/302,3662,3832,3452,361-0.04%153,000679億9680万-10.06%
08/292,3572,3702,3502,362+0.08%210,300680億2560万-10.67%
08/282,4032,4252,3432,360-12.69%491,200679億6800万-11.24%
08/27(IR情報)15:00 抗HIV薬6品の日本国内における独占的開発・商業化権に関する契約及び独占的販売権に関する契約の解消に向けた意思確認書の締結について
08/272,7012,7072,6632,703+0.07%13,100778億4640万+1.2%
08/242,7422,7432,6812,701-0.63%18,700777億8880万+1.2%
08/232,7132,7492,7032,718+0.11%22,000782億7840万+1.95%
08/222,6212,7172,6212,715+3.71%35,700781億9200万+1.88%